$SNTA MADRIGAL PHARMACEUTICALS, INC. Insider Trading Week 27/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MADRIGAL PHARMACEUTICALS, INC. in week 27/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | KUFE DONALD W | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 2.20 | 15,000 | 33,000 | 15,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,545 | 0 | 401,764 | 397.2 K to 401.8 K (+1.14 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,545 | 0 | 397,219 | 392.7 K to 397.2 K (+1.16 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,545 | 0 | 392,674 | 388.1 K to 392.7 K (+1.17 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 13,636 | 0 | 388,129 | 374.5 K to 388.1 K (+3.64 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 22,727 | 0 | 374,493 | 351.8 K to 374.5 K (+6.46 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 6,818 | 0 | 760,936 | 754.1 K to 760.9 K (+0.90 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 1,136 | 0 | 6,817 | 5.7 K to 6.8 K (+20.00 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 5,681 | 0 | 5,681 | 0 to 5.7 K |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 2,272 | 0 | 49,392 | 47.1 K to 49.4 K (+4.82 %) |
| Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 5,681 | 0 | 47,120 | 41.4 K to 47.1 K (+13.71 %) |